药剂师驱动的骨关节炎防护:使用患者教育,信息可视化和生活方式整合的多方面的方法
1Independent Researcher, 11520 Cádiz, Spain.
Pharmacy (Basel, Switzerland)
|August 27, 2025
概括
本综述探讨了骨关节炎 (OA) 的药理性护理,为药剂师引入了指导疾病修饰性骨关节炎药物 (DMOAD) 选择和时间治疗的框架,旨在预防OA护理.
科学领域:
- 药理学和骨关节炎治疗
- 生物医学工程和药物交付
- 医疗服务研究和专业间护理
背景情况:
- 骨关节炎 (OA) 引起显著的疼痛和残疾,目前的治疗主要是反应性的,以症状为重点.
- 在骨髓炎中不可逆转的软骨损失需要转向预防性疾病修饰策略.
- 常规的胆固醇保护剂如葡萄糖胺和胆固醇硫酸盐显示出细胞外基质恢复和滑的潜力,但面临着传递挑战.
研究的目的:
- 审查关节炎中药理性防护的机制基础.
- 为药剂师在选择和使用疾病修饰性关节炎药物 (DMOADs) 提供实用框架.
- 为主动,以团队为基础的OA管理提出一个综合的P4-4P冠状病毒保护框架.
主要方法:
- 对药理性肌肉保护的机制基础的审查.
- 一个实用的介绍
- 什么-如何-什么时候
- 这是社区药剂师的框架.
- 关于P4-4P冠状病毒保护框架的建议,其中包括预测分析,药理动力学,生物力学和自我管理.
主要成果:
- 常规药物可以恢复细胞外基质,减弱代谢酶,增强关节滑.
- 提出了一个框架来指导药剂师进行风险查,选择DMOAD,慢性治疗和监测.
- P4-4P框架统一了预测,预防,个性化和参与性的OA护理方法.
结论:
- 为了保护软骨和改善生活质量, 转向主动的疾病修饰性关节炎治疗至关重要.
- 实施需要DMOAD指导方针,课程整合,多学科途径,以及来自试验的强有力的证据.
- 同步的DMOAD和运动干预有望在OA中带来长期的结构和功能益处.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Peripheral Artery Disease IV: Nursing Management
43
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50


